Texas Retina Associates

Home
United States
Dallas, TX
Texas Retina Associates

Texas Retina Associates is North Texas’ largest, most experienced ophthalmology practice focused specifically on retina care.
(247)

11/20/2025

Today is the Great American Smokeout.

Smoking remains the single largest cause of preventable disease and premature death in the United States. You probably know that smoking increases your risk of developing heart disease, stroke and cancer. Did you know it can also harm your eye health and vision? The good news is that quitting smoking at any age can significantly reduce your risk.

Learn more in our latest blog: https://www.texasretina.com/2025/11/20/how-smoking-can-affect-your-eye-health

11/18/2025

“Caregiving often calls us to lean into love we didn’t know possible.” – Tia Walker

Did you know that more than 63 million Americans are now caregivers? That is one in every four adults.

In honor of National Family Caregivers Month, Texas Retina would like to recognize and thank all the humble, unsung heroes who selflessly give their time, energy and love to support and care for family members, friends and neighbors with health needs. Your compassion and dedication make all the difference.

11/14/2025

At Texas Retina, we take caring for our patients and maintaining their vision personally. That is why we love receiving patient feedback like this about Dr. Lin, who joined our team in September after completing his training at the world-renowned Bascom Palmer Eye Institute at the University of Miami. He cares for patients in our Dallas Main, Dallas North and Plano offices.

Learn more about Dr. Lin: https://www.texasretina.com/our-physicians/benjamin-r-lin-md

11/13/2025

Diabetes damages blood vessels all over the body, including in the eye. This can lead to conditions like diabetic retinopathy and diabetic macular edema. However, the good news is that about 90% of vision loss from diabetes can be prevented.

In recognition of National Diabetes Month and Diabetic Eye Disease Awareness Month, we explain more about diabetic eye disease and share 6 steps you can take to help protect your eyes and vision in our latest blog: https://www.texasretina.com/2025/11/13/control-your-diabetes-to-protect-your-vision

11/11/2025

On behalf of everyone at Texas Retina, we would like to extend our deepest gratitude for the sacrifices that our service members, both past and present, have made for our country.

11/07/2025

On October 28, 2025, Texas Retina’s Dr. Ashkan Abbey dosed the first patient in the Phase 1b/2a LOTUS-2 clinical trial of novel multivalent fusion antibody (EB-105) for diabetic macular edema (DME).

In June 2025, Eluminex Biosciences Inc., the maker of EB-105, announced positive topline safety, tolerability and pharmacodynamic data from the multicenter LOTUS Part 1 clinical in patients with vision-threatening DME. Texas Retina was one of five sites for that study and enrolled the most patients with Dr. Abbey serving as a Principal Investigator and dosing the first patient.

Learn more about this new clinical trial in our latest blog: https://www.texasretina.com/2025/11/06/dr-abbey-doses-first-patient-in-phase-1b-2a-lotus-2-clinical-trial-of-novel-multivalent-fusion-antibody-eb-105-for-diabetic-macular-edema

11/05/2025

We’re excited to announce that our own Dr. Rene Choi was inducted into the prestigious International Retina Imaging Society (IntRIS) on October 29, 2025.

Comprised of physicians and scientists, IntRIS is selective with just 187 members worldwide and only 83 in the United States. Applicants are evaluated based on their contributions to the field of retina and retinal imaging.

Read more in our latest blog: https://www.texasretina.com/2025/11/03/dr-rene-choi-inducted-into-international-retina-imaging-society

11/03/2025

Conducting ongoing research that advances retinal care is a value that was instilled by the pioneering physicians who founded our practice more than 50 years ago. Over time, this work has helped lead to new sight-saving treatments for diseases that once robbed patients of their vision.

Texas Retina remains committed to conducting ongoing research that will advance retinal care and recently opened 6 new clinical trials, offering our patients access to promising new treatments for diabetic macular edema, age-related macular degeneration, retinal vein occlusion, uveal melanoma, and uveitis.

Learn more: https://www.texasretina.com/2025/11/03/new-clinical-trials-available-at-texas-retina-5

10/31/2025

Happy Halloween from Texas Retina! Our physicians and staff brought some Halloween fun to their offices today!

10/29/2025

Our own Dr. Ashkan Abbey presented, taught and served as a panelist at AAO 2025, the American Academy of Ophthalmology’s annual meeting held in Orlando, Florida, October 18-20, 2025. Read highlights of his work in our latest blog: https://www.texasretina.com/2025/10/28/dr-ashkan-abbey-presented-at-the-american-academy-of-ophthalmology-annual-meeting

10/27/2025

“Dr. Rene Choi is an exceptional ophthalmologist, distinguished by his unwavering integrity and outstanding kindness and compassion towards his patients. He combines superb clinical and surgical skills in treating retinal and inflammatory diseases with a genuinely warm demeanor. It has been some years since completing training, and he continues to be solidly regarded as one of the most effective and beloved fellows to have graduated from OHSU Casey Eye Institute.”

— Andy Lauer, MD, Chair and Director of Ophthalmology at the Casey Eye Institute, Past Chair and Director, American Board of Ophthalmology

At AAO 2025, the American Academy of annual meeting held in Orlando, Florida, October 18-20, 2025, our own Dr. Rene Y. Choi was presented the “One to Watch” award, a peer-nominated honor given to upcoming doctors in the field of retina who are considered future leaders.

Learn more in our latest blog: https://www.texasretina.com/2025/10/26/texas-retinas-dr-rene-choi-receives-one-to-watch-award-at-aao-2025

10/23/2025

We’re excited to announce that on October 14, 2025, Texas Retina broke ground on a brand new, state-of-the-art eye care complex to better serve the Frisco, Texas community. Scheduled to open in late 2026, this new office will eventually replace our current Frisco office.

At twice the size, it will better serve our patients in this rapidly growing area while also incorporating space for clinical research and a dedicated ophthalmology ambulatory surgical center (ASC) available for retina surgeries as well as for general ophthalmology and a full range of ophthalmology subspecialty surgical procedures.

Learn more: https://www.texasretina.com/2025/10/23/texas-retina-breaks-ground-on-new-frisco-ophthalmology-complex

Address

Dallas, TX

Telephone

+12146926941

Website

http://www.texasretina.com/

Alerts

Be the first to know and let us send you an email when Texas Retina Associates posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Shortcuts

Featured

Psych Dimensions

Want your practice to be the top-listed Clinic in Dallas?